GeminIQ Website Logo

Viewing CATX free

Subscribe for full history, 50+ metrics, screener, watchlist...

Perspective Therapeutics, Inc.

CATX

Companies in Pharmaceutical Preparations

Perspective Therapeutics, Inc. (CATX) — SEC Financial Statements & Analysis

Perspective Therapeutics, Inc. (CATX) files its annual 10-K and quarterly 10-Q reports directly with the SEC. The financial data below is sourced as-filed from EDGAR — balance sheet, income statement, and cash flow as reported, without normalization or third-party adjustments.

Subscribe to unlock 17+ years of data

Financial Statements

Values in Millions ($)
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial
Subscriber-only column
Assets
Cash And Cash Equivalents At Carrying Value
54312729446222625214291828
Short Term Investments
217114147163167165414139000
Notes Receivable Net
---------000
Assets Current
Accounts Receivable Net Current
000000001121
Assets Current
275148179196216231270294188172232
Inventory Net
----------11
Assets Of Disposal Group Including Discontinued Op…
-----00055--
Prepaid Expense And Other Assets Current
444444211111
Assets Noncurrent
Inventory Noncurrent
----------22
Intangible Assets Net Excluding Goodwill
----------5050
Property Plant And Equipment Net
927764636157441514677
Operating Lease Right Of Use Asset
222222221121
Restricted Cash And Cash Equivalents Noncurrent
---000000000
Indefinite Lived Intangible Assets Excluding Goodw…
40405050505050505050--
Goodwill
-----0242424242727
Other Assets Noncurrent
000000110011
Disposal Group Including Discontinued Operation As…
---------0--
Assets
41126729531132934139138627898111120
Liabilities And Stockhold…
Accounts Payable And Accrued Liabilities Current
26211379102266745
Operating Lease Liability Current
111111110000
Accounts Payable And Other Accrued Liabilities Cur…
---------000
Employee Related Liabilities Current
47753542-4--
Liabilities Current
Liabilities Current
3129211313182811151689
Other Liabilities Current
---------000
Notes Payable Current
0000000000--
Accrued Vacation Current
---------011
Deferred Income Current
-000011110--
Other Notes Payable Current
---------000
Liabilities Other Than Lo…
Operating Lease Liability Noncurrent
211111211111
Long Term Notes Payable
222222222222
Asset Retirement Obligations Noncurrent
----------11
Liabilities Of Disposal Group Including Discontinu…
-----00055--
Deferred Income Noncurrent
2727272727272727270--
Liabilities Of Disposal Group Including Discontinu…
---------0--
Deferred Income Tax Liabilities Net
2222225555--
Other Liabilities Noncurrent
00000000-0--
Liabilities
636053454550634548231211
Preferred Stock Value
000000000000
Common Stock Value
000000001000
Additional Paid In Capital Common Stock
709542539537534522520517394228226226
Stockholders Equity
Stockholders Equity
3472072422662852913283412307599109
Accumulated Other Comprehensive Income Loss Net Of…
-00000-0------
Retained Earnings Accumulated Deficit
-361-335-297-271-250-232-192-176-165-152-128-117
Liabilities And Stockholders Equity
41126729531132934139138627898111120
Allowance For Doubtful Accounts Receivable
0000111111--
Preferred Stock Par Or Stated Value Per Share
0.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.001
Preferred Stock Shares Authorized
777777777777
Common Stock Par Or Stated Value Per Share
0.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.001
Common Stock Shares Authorized
750750750750750750750750750750750750
Common Stock Shares Issued
684669669668666636608607587564561561
Shares Outstanding
1147474747471686749565656

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Custom Table

0/5
Search a metric to start building a table

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Interactive Financial Visualizations

0/1
Search a metric to start building a visual

Subscribe to unlock 17+ years of data

Earnings Market Reaction

Fiscal Year
Q1 1 Month
Q1 2 Month
Q1 3 Month
Q2 1 Month
Q2 2 Month
Q2 3 Month
Q3 1 Month
Q3 2 Month
Q3 3 Month
Q4 1 Month
Q4 2 Month
Q4 3 Month
20268.11%25.68%70.72%----21.91%-6.44%----
2025-64.76%-67.10%-66.73%-9.19%-4.46%-28.35%32.27%46.61%46.61%-14.37%-27.97%-41.95%
20248.70%169.57%269.57%19.41%4.46%-5.40%-23.57%-31.72%-21.72%-14.54%15.86%39.65%
2023----14.58%-43.75%-45.83%-20.00%0.00%-13.85%26.05%34.45%-10.08%

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data and 50+ calculated metrics

Performance and Valuation Metrics

Metrics
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial
Subscriber-only column
Liquidity Ratios
Current Ratio
8.75
5.17
8.66
15.09
17.02
12.68
9.60
27.73
12.98
1.07
2.67
3.72
Quick Ratio
8.61
5.05
8.45
14.77
16.70
12.45
9.53
27.62
12.89
1.00
2.43
3.43
Working Capital
243.87M
119.71M
157.88M
182.97M
203.06M
212.93M
242.03M
283.63M
173.70M
1.17M
13.57M
23.37M
Leverage & Debt
Debt to Equity
0.18
0.29
0.22
0.17
0.16
0.17
0.19
0.13
0.21
0.30
0.12
0.11
Interest Coverage TTM
-
-
-
-
-
-
-1,661.05
-1,043.00
-621.59
-474.32
-557.88
-540.37
Debt Ratio
0.15
0.22
0.18
0.14
0.14
0.15
0.16
0.12
0.17
0.23
0.11
0.10
Efficiency & Turnover
Asset Turnover TTM
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.01
0.02
0.07
0.08
0.08
Days Sales Outstanding TTM
-
-
-
-
-
-
-
119.98
106.96
82.84
87.60
78.61
Receivables Turnover TTM
0.00
0.00
0.00
0.00
0.00
0.00
0.00
3.04
3.41
4.41
4.17
4.64
Per Share Metrics
Diluted EPS TTM
-1.18
-1.54
-1.49
-1.34
-1.24
-1.30
-0.99
-0.98
-1.31
-1.97
-0.92
-0.63
Free Cash Flow Per Share TTM
-2.34
-3.12
-2.11
-1.01
-0.89
-0.52
-0.30
-1.18
-1.57
-1.72
-0.88
-0.19
Dividend Per Share TTM
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Margin Metrics
Gross Profit Margin TTM
-
-
-
-
-
-
-
-
-
33.56%
27.13%
-33.65%
Operating Profit Margin TTM
-
-
-
-
-
-
-
-2,841.07%
-1,458.70%
-887.25%
-481.21%
-329.14%
Net Profit Margin TTM
-
-
-
-
-
-
-
-3,421.01%
-1,898.18%
-1,007.75%
-372.35%
-233.36%
Growth Metrics
Net Revenue Growth (1Y)
-
-
-
-100.00%
-100.00%
-100.00%
-100.00%
-74.72%
-61.96%
-47.34%
-35.56%
-31.35%
Net Income Growth (1Y)
35.63%
35.60%
57.79%
52.69%
38.99%
59.19%
170.54%
270.58%
722.85%
480.37%
256.17%
181.61%
EPS Growth (1Y)
-5.28%
18.36%
50.00%
37.09%
-4.90%
32.26%
114.93%
211.36%
849.79%
670.19%
350.65%
257.15%
Valuation Metrics
P/E TTM
-3.54
-1.78
-2.30
-2.56
-1.71
-2.45
-13.46
-10.17
-9.10
-4.06
-5.85
-21.29
P/B
1.24
0.98
1.05
0.96
0.54
0.71
2.87
1.95
2.56
2.85
1.53
3.45
P/S TTM
-
-
-
-
-
-
-
348.08
172.83
40.87
21.78
49.68
Market Cap
432.03M
202.99M
254.84M
255.37M
154.12M
205.52M
942.90M
664.48M
589.17M
214.11M
151.50M
375.19M
Enterprise Value
379.67M
173.98M
229.71M
228.17M
111.38M
145.61M
718.14M
414.18M
448.76M
206.60M
135.20M
348.57M
Calculated Values
Free Cash Flow TTM
-242.65M
-230.57M
-156.54M
-75.31M
-64.25M
-33.23M
-21.10M
-78.78M
-77.49M
-92.19M
-49.32M
-10.36M
Net Debt
-52.36M
-29.00M
-25.12M
-27.20M
-42.74M
-59.90M
-224.75M
-250.30M
-140.40M
-7.51M
-16.29M
-26.62M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of data

Insider Transactions

2025-11-13Purchase
Owner: Hunt, Jonathan Robert
Title: Chief Accounting Officer
Shares: 11,000
Price/Share: $2.03
Value: $22,330.00
Shares Owned: 59,800
Relationship: Officer
Ownership: Direct
2025-11-12Purchase
Owner: Williamson, Robert F Iii
Title: -
Shares: 9,498
Price/Share: $2.10
Value: $19,945.80
Shares Owned: 9,864
Relationship: Director
Ownership: Indirect
2025-03-31Purchase
Owner: Woods, Lori A
Title: -
Shares: 23,475
Price/Share: $2.13
Value: $50,001.75
Shares Owned: 183,460
Relationship: Director
Ownership: Indirect
2025-03-31Purchase
Owner: Williamson, Robert F Iii
Title: -
Shares: 38,145
Price/Share: $2.14
Value: $81,630.30
Shares Owned: 108,982
Relationship: Director
Ownership: Direct
2025-03-28Purchase
Owner: Graham, Juan
Title: Chief Financial Officer
Shares: 33,333
Price/Share: $2.25
Value: $74,999.25
Shares Owned: 35,354
Relationship: Officer
Ownership: Direct

Subscribe to unlock 17+ years of data

Institutional Ownership

No data available for chart
2026-03-31
75.68%
Inst. Shares: 78,406,104
Shares Outstanding: 103,604,000
2025-12-31
98.09%
Inst. Shares: 72,399,578
Shares Outstanding: 73,813,000
2025-09-30
114.35%
Inst. Shares: 84,957,804
Shares Outstanding: 74,296,000
2025-06-30
113.39%
Inst. Shares: 84,175,108
Shares Outstanding: 74,235,000
2025-03-31
115.38%
Inst. Shares: 83,484,536
Shares Outstanding: 72,357,000

Research Faster.
Invest Smarter.

Perspective Therapeutics, Inc. (CATX) financial data sourced directly from SEC EDGAR filings — including the latest 10-K annual report, 10-Q quarterly filings, insider transactions (SEC Form 4), institutional ownership (SEC Form 13F), Earning Marker Reaction Heat Map and 50+ calculated financial metrics like Price to Earnings Ratio (P/E), Return on Equity (ROE), Debt to Equity (D/E), Free Cash Flow Per Share (FCF/S), and Return on Invested Capital (ROIC). Unlike platforms that rely on third-party data aggregators, GeminIQ parses raw SEC filings directly — delivering institutional-grade accuracy at a fraction of the cost of Bloomberg Terminal or S&P Capital IQ.